Caissa Capital Management ltd. 4
4 · Avalo Therapeutics, Inc. · Filed Jun 14, 2023
Insider Transaction Report
Form 4
Caissa Capital Management ltd.
10% Owner
Transactions
- Purchase
Common Stock
2023-06-12$4.34/sh+2,149$9,316→ 1,402,790 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-13$3.82/sh+8,750$33,439→ 1,411,540 total(indirect: See Footnote (1)) - Purchase
Common Stock
2023-06-14$3.48/sh+6,000$20,874→ 1,417,540 total(indirect: See Footnote (1))
Holdings
- 182,300
Common Stock
Footnotes (5)
- [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.125 to $4.47, inclusive.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7 to $3.83, inclusive.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.245 to $3.55, inclusive.
- [F5]These shares are directly owned by Mr. Golestaneh in his personal capacity.